Rotavirus Vaccine Market Report 2026
Download Free Sample Buy Now
Rotavirus Vaccine Market Global Report 2026 Market Report Infographic Image

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Rotavirus Vaccine Market Report 2026

Global Outlook – By Type (Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types), By Application (Adult, Pediatric), By End Users (Hospitals, Clinics, Academic Research) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Rotavirus Vaccine Market Overview

• Rotavirus Vaccine market size has reached to $10.14 billion in 2025

• Expected to grow to $16.45 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%

• Growth Driver: Impact Of Rising Birth Rates On Rotavirus Vaccine Market Growth

• Market Trend: Oral-Dosing Applicators Enhance Rotavirus Vaccine Delivery And Compliance

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rotavirus Vaccine Market?

The rotavirus vaccine refers to a vaccine designed to protect against rotavirus infections, which are a common cause of severe diarrhea and gastroenteritis in infants and young children. This vaccine is administered orally and contains live attenuated or inactivated strains of the rotavirus to stimulate an immune response and provide immunity against the virus.

The main types of rotavirus vaccine include rotarix, rotateq, rotavac, rotavin-M1, lanzhou lamb, and others. Rotarix is a live attenuated oral rotavirus vaccine designed to protect infants from rotavirus gastroenteritis, which can cause severe diarrhea and dehydration. The application are categorized into adult and pediatric for end users including hospitals, clinics, and academic research.

Rotavirus Vaccine Market Global Report 2026 Market Report bar graph

What Is The Rotavirus Vaccine Market Size and Share 2026?

The rotavirus vaccine market size has grown rapidly in recent years. It will grow from $10.14 billion in 2025 to $11.2 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to increasing incidence of pediatric gastroenteritis, expansion of national immunization schedules, growth of public health vaccination campaigns, availability of live attenuated vaccines, rising awareness of rotavirus prevention.

What Is The Rotavirus Vaccine Market Growth Forecast?

The rotavirus vaccine market size is expected to see rapid growth in the next few years. It will grow to $16.45 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for universal pediatric vaccination, expansion of combination vaccine development, growing investments in vaccine manufacturing capacity, rising focus on global immunization coverage, increasing collaboration with public health agencies. Major trends in the forecast period include increasing expansion of pediatric immunization programs, rising adoption of oral vaccine formulations, growing focus on vaccine cold chain optimization, expansion of public health vaccination initiatives, enhanced surveillance of rotavirus infections.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Rotavirus Vaccine Market Segmentation

1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types

2) By Application: Adult, Pediatric

3) By End Users: Hospitals, Clinics, Academic Research

What Is The Driver Of The Rotavirus Vaccine Market?

The rising birth rates are expected to propel the growth of the rotavirus vaccine market going forward. Birth rates refer to the number of live births per 1,000 people in a population over a specific period, typically expressed annually. Birth rates are influenced by higher economic stability and growth, as well as supportive policies such as parental leave, child benefits, and childcare subsidies. The use of rotavirus vaccines helps to reduce the incidence of severe rotavirus gastroenteritis in infants, thereby improving child health outcomes and reducing healthcare costs associated with rotavirus infections. For instance, in January 2023, according to a report published by the Centers for Disease Control and Prevention, a US-based national public health organization, the United States witnessed a 1% increase in registered births, totaling 3,664,292, compared to the previous year. Therefore, rising birth rates will drive the growth of the rotavirus vaccine industry.

Key Players In The Global Rotavirus Vaccine Market

Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd

Global Rotavirus Vaccine Market Trends and Insights

Major companies operating in the rotavirus vaccine market are adopting oral-dosing applicators to enhance vaccine delivery efficiency and improve patient compliance. Oral-dosing applicators are medical devices designed to administer liquid medications or vaccines directly into the mouth, ensuring accurate dosage and ease of use, especially for infants and young children. For instance, in June 2025, Micron Biomedical, a U.S.-based biotechnology company, and Emory University, a U.S.-based private university, launched a first-in-human clinical trial of the inactivated rotavirus vaccine CC24 delivered via a dissolvable microarray patch. This patch is thermostable (reduces cold chain dependence), enables self-administration, and produces no sharps waste. This innovation promises greater vaccine access in low-resource settings, although regulatory pathways remain untested, and scale-up risks may delay broad adoption in the rotavirus vaccine market.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Rotavirus Vaccine Market?

In June 2024, Murdoch Children's Research Institute, an Australia-based child health research institute, partnered with Incepta Pharmaceuticals Limited to improve access to rotavirus vaccines. The collaboration between MCRI and Incepta Pharmaceuticals is designed to advance the protection of children against rotavirus by developing and distributing effective vaccines. This partnership is dedicated to expanding access to critical rotavirus vaccines, targeting regions with high infection rates and limited healthcare resources. Incepta Pharmaceuticals Limited is a Bangladesh-based pharmaceutical company that is developing rotavirus vaccines.

Regional Insights

North America was the largest region in the rotavirus vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rotavirus Vaccine Market?

The rotavirus vaccine market consists of sales of combination vaccines, vaccine delivery systems, vaccine doses, and packs. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rotavirus Vaccine Market Report 2026?

The rotavirus vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the rotavirus vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Rotavirus Vaccine Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $11.2 billion
Revenue Forecast In 2035 $16.45 billion
Growth Rate CAGR of 10.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Application, End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Rotavirus Vaccine Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Rotavirus Vaccine Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Rotavirus Vaccine Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Rotavirus Vaccine Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.1.5 Digitalization, Cloud, Big Data & Cybersecurity

4.2. Major Trends

4.2.1 Increasing Expansion Of Pediatric Immunization Programs

4.2.2 Rising Adoption Of Oral Vaccine Formulations

4.2.3 Growing Focus On Vaccine Cold Chain Optimization

4.2.4 Expansion Of Public Health Vaccination Initiatives

4.2.5 Enhanced Surveillance Of Rotavirus Infections

5. Rotavirus Vaccine Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Public Health Organizations

5.4 Pediatric Care Centers

5.5 Academic Research Institutes

6. Rotavirus Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Rotavirus Vaccine Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Rotavirus Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Rotavirus Vaccine Market Size, Comparisons And Growth Rate Analysis

7.3. Global Rotavirus Vaccine Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Rotavirus Vaccine Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Rotavirus Vaccine Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Rotavirus Vaccine Market Segmentation

9.1. Global Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types

9.2. Global Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult, Pediatric

9.3. Global Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Academic Research

10. Rotavirus Vaccine Market Regional And Country Analysis

10.1. Global Rotavirus Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Rotavirus Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Rotavirus Vaccine Market

11.1. Asia-Pacific Rotavirus Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Rotavirus Vaccine Market

12.1. China Rotavirus Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Rotavirus Vaccine Market

13.1. India Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Rotavirus Vaccine Market

14.1. Japan Rotavirus Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Rotavirus Vaccine Market

15.1. Australia Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Rotavirus Vaccine Market

16.1. Indonesia Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Rotavirus Vaccine Market

17.1. South Korea Rotavirus Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Rotavirus Vaccine Market

18.1. Taiwan Rotavirus Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Rotavirus Vaccine Market

19.1. South East Asia Rotavirus Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Rotavirus Vaccine Market

20.1. Western Europe Rotavirus Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Rotavirus Vaccine Market

21.1. UK Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Rotavirus Vaccine Market

22.1. Germany Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Rotavirus Vaccine Market

23.1. France Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Rotavirus Vaccine Market

24.1. Italy Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Rotavirus Vaccine Market

25.1. Spain Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Rotavirus Vaccine Market

26.1. Eastern Europe Rotavirus Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Rotavirus Vaccine Market

27.1. Russia Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Rotavirus Vaccine Market

28.1. North America Rotavirus Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Rotavirus Vaccine Market

29.1. USA Rotavirus Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Rotavirus Vaccine Market

30.1. Canada Rotavirus Vaccine Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Rotavirus Vaccine Market

31.1. South America Rotavirus Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Rotavirus Vaccine Market

32.1. Brazil Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Rotavirus Vaccine Market

33.1. Middle East Rotavirus Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Rotavirus Vaccine Market

34.1. Africa Rotavirus Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Rotavirus Vaccine Market, Segmentation By Type, Segmentation By Application, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Rotavirus Vaccine Market Regulatory and Investment Landscape

36. Rotavirus Vaccine Market Competitive Landscape And Company Profiles

36.1. Rotavirus Vaccine Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Rotavirus Vaccine Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Rotavirus Vaccine Market Company Profiles

36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Daiichi Sankyo Company Limited Overview, Products and Services, Strategy and Financial Analysis

37. Rotavirus Vaccine Market Other Major And Innovative Companies

Serum Institute of India Private Limited, Sinovac Biotech Ltd., SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd.

38. Global Rotavirus Vaccine Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Rotavirus Vaccine Market

40. Rotavirus Vaccine Market High Potential Countries, Segments and Strategies

40.1 Rotavirus Vaccine Market In 2030 - Countries Offering Most New Opportunities

40.2 Rotavirus Vaccine Market In 2030 - Segments Offering Most New Opportunities

40.3 Rotavirus Vaccine Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Rotavirus Vaccine Market, Overview Of Key Products - Product Examples
  • Table 2: Global Rotavirus Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Rotavirus Vaccine Market, Supply Chain Analysis
  • Table 4: Global Rotavirus Vaccine Market, Major Raw Material Providers
  • Table 5: Global Rotavirus Vaccine Market, Major Resource Providers
  • Table 6: Global Rotavirus Vaccine Market, Major Manufacturers (Suppliers)
  • Table 7: Global Rotavirus Vaccine Market, Major Distributors And Channel Partners
  • Table 8: Global Rotavirus Vaccine Market, Key Technologies & Future Trends
  • Table 9: Global Rotavirus Vaccine Market, Major Trends
  • Table 10: Global Rotavirus Vaccine Market, Major End Users
  • Table 11: Global Rotavirus Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Rotavirus Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Rotavirus Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Rotavirus Vaccine Market - TAM, US$ Billion, 2025
  • Table 15: Global Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Rotavirus Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Rotavirus Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Asia-Pacific, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Asia-Pacific, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: China, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: China, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: India, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: India, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Japan, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: Japan, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Australia, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Australia, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Indonesia, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Indonesia, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: South Korea, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: South Korea, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Taiwan, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Taiwan, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South East Asia, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South East Asia, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Western Europe, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Western Europe, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: UK, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: UK, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Germany, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Germany, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: France, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: France, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Italy, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Italy, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Spain, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Spain, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Eastern Europe, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Eastern Europe, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Russia, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Russia, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: North America, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: North America, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: USA, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: USA, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Canada, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: Canada, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: South America, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: South America, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Brazil, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Brazil, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Middle East, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Middle East, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Africa, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Africa, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Global Rotavirus Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 93: Global Rotavirus Vaccine Market - Company Scoring Matrix
  • Table 94: Merck & Co. Inc. Financial Performance
  • Table 95: Sanofi S.A. Financial Performance
  • Table 96: Abbott Laboratories Financial Performance
  • Table 97: GlaxoSmithKline plc Financial Performance
  • Table 98: Daiichi Sankyo Company Limited Financial Performance
  • Table 99: Global Rotavirus Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Table 100: Global Rotavirus Vaccine Market, Competitive Dashboard
  • Table 101: Global Rotavirus Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 102: Global, Rotavirus Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 103: Global, Rotavirus Vaccine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Table 104: Global, Rotavirus Vaccine Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

List Of Figures

    Figure 1: Global Rotavirus Vaccine Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Rotavirus Vaccine Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Rotavirus Vaccine Market, Supply Chain Analysis
  • Figure 4: Global Rotavirus Vaccine Market, Major Raw Material Providers
  • Figure 5: Global Rotavirus Vaccine Market, Major Resource Providers
  • Figure 6: Global Rotavirus Vaccine Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Rotavirus Vaccine Market, Major Distributors And Channel Partners
  • Figure 8: Global Rotavirus Vaccine Market, Key Technologies & Future Trends
  • Figure 9: Global Rotavirus Vaccine Market, Major Trends
  • Figure 10: Global Rotavirus Vaccine Market, Major End Users
  • Figure 11: Global Rotavirus Vaccine Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Rotavirus Vaccine Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Rotavirus Vaccine Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Rotavirus Vaccine Market - TAM, US$ Billion, 2025
  • Figure 15: Global Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Rotavirus Vaccine Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Rotavirus Vaccine Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Asia-Pacific, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Asia-Pacific, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: China, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: China, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: India, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: India, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Japan, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: Japan, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Australia, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Australia, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Indonesia, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Indonesia, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: South Korea, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: South Korea, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Taiwan, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Taiwan, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South East Asia, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South East Asia, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Western Europe, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Western Europe, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: UK, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: UK, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Germany, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Germany, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: France, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: France, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Italy, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Italy, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Spain, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Spain, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Eastern Europe, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Eastern Europe, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Russia, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Russia, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: North America, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: North America, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: USA, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: USA, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Canada, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: Canada, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: South America, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: South America, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Brazil, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Brazil, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Middle East, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Middle East, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Africa, Rotavirus Vaccine Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Africa, Rotavirus Vaccine Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Rotavirus Vaccine Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Global Rotavirus Vaccine Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 93: Global Rotavirus Vaccine Market - Company Scoring Matrix
  • Figure 94: Merck & Co. Inc. Financial Performance
  • Figure 95: Sanofi S.A. Financial Performance
  • Figure 96: Abbott Laboratories Financial Performance
  • Figure 97: GlaxoSmithKline plc Financial Performance
  • Figure 98: Daiichi Sankyo Company Limited Financial Performance
  • Figure 99: Global Rotavirus Vaccine Market, Competitive Benchmarking (In USD Billions)
  • Figure 100: Global Rotavirus Vaccine Market, Competitive Dashboard
  • Figure 101: Global Rotavirus Vaccine Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 102: Global, Rotavirus Vaccine Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 103: Global, Rotavirus Vaccine Market Size Gain ($ Billion), Segmentation By Application, 2025 – 2030
  • Figure 104: Global, Rotavirus Vaccine Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Meningococcal Vaccines Market Report 2026 - Global Outlook – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Childre...

Swine Vaccines Market Report 2026 - Global Outlook – By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, Deoxyribonucleic Acid (DNA) Vaccines, Recombinant Vaccines), By Disease (Viral Infections...

Typhoid Vi Polysaccharide Vaccine Market Report 2026 - Global Outlook – By Type (Child, Adult ), By Route Of Administration (Oral, Parenteral ), By Application (Government Institution, Private Sector, Other Applications ...

Dog Vaccines Market Report 2026 - Global Outlook – By Type (Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines), By Route Of Administ...

Foot And Mouth Disease Vaccine Market Report 2026 - Global Outlook – By Vaccine Type (Conventional Vaccines, Oil Based Vaccines, Aluminum Hydroxide Or Saponin Based Vaccines, Emergency Vaccines), By Animal Type (Cattle, ...

Chickenpox Vaccine Market Report 2026 - Global Outlook – By Vaccine (Monovalent Varicella Vaccine, Combination Varicella Vaccine), By Application (Mumps, Measles, Rubella, And Varicella Immunization, Herpes Zoster Immuni...

Poultry Vaccines Market Report 2026 - Global Outlook – By Type (Porcine Vaccines, Poultry Vaccine, Livestock Vaccine, Companion Animal Vaccine, Aquaculture Vaccines, Other Animal Vaccines), By Disease Type (Avain Influen...

Porcine Vaccine Market Report 2026 - Global Outlook – By Technology (Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines), By Disease Indication (Diarrh...

Frequently Asked Questions

The Rotavirus Vaccine market was valued at $10.14 billion in 2025, increased to $11.2 billion in 2026, and is projected to reach $16.45 billion by 2030.

The global Rotavirus Vaccine market is expected to grow at a CAGR of 10.1% from 2026 to 2035 to reach $16.45 billion by 2035.

Some Key Players in the Rotavirus Vaccine market Include, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd. , SK Chemicals Co Ltd, Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd .

Major trend in this market includes: Oral-Dosing Applicators Enhance Rotavirus Vaccine Delivery And Compliance. For further insights on this market. request a sample here

North America was the largest region in the rotavirus vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us